J&J/Merck
This article was originally published in The Tan Sheet
Executive Summary
Form OTC joint venture in the U.K. called Centra Healthcare. Among the first products to be marketed by Centra is an OTC version of Merck's H[2] antagonist Pepcid (famotidine), which was recently cleared for over-the-counter status in the U.K. Centra will be headed by Collin Mackenzie and is expected to begin marketing products in the first quarter of 1994.